| Literature DB >> 17634134 |
Kivanc Akca1, Ebru Sarac, Ugur Baysal, Mete Fanuscu, Ting-Ling Chang, Murat Cehreli.
Abstract
BACKGROUND: Osteoporosis may present a risk factor in achievement of osseointegration because of its impact on bone remodeling properties of skeletal phsiology. The purpose of this study was to evaluate micro-morphological changes in bone around titanium implants exposed to mechanical and electrical-energy in osteoporotic rats.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17634134 PMCID: PMC1947957 DOI: 10.1186/1746-160X-3-28
Source DB: PubMed Journal: Head Face Med ISSN: 1746-160X Impact factor: 2.151
ALP levels (U/L) before and after ovariectomy in randomly selected 5 animals.
| Animal | BO | AO |
| #1 | 72 | 285 |
| #2 | 76 | 305 |
| #3 | 87 | 298 |
| #4 | 78 | 312 |
| #5 | 85 | 264 |
BO: Before ovariectomy; AO: after ovariectomy
Figure 1Fabricated custom-made device to deliver PEMF stimulation on osteoporotic rats.
Figure 2Plexiglass bordered vibrating plate used to administer mechanical low-magnitude high-frequency to osteoporotic rats.
Figure 33a and 3b. 3-D microCT view of a titanium implant (a) and illustration of defined peri-implant VOIs (b).)
Figure 43-D microCT view of VOI 1–3 (from left to right) around control (top), PEMF-stimulated (middle), and MECHVIB-stimulated (bottom) implants.
ANOVA of peri-implant relative bone volume (BV/TV: %) around implants of test and control groups (n = 15).
| p | Group | Mean | Std. Deviation | Std. Error | 95% Confidence interval for mean | Minimum | |||
| Lower Bound | Upper Bound | ||||||||
| VOI-1 | 0.000 | Control | 4.0 | 0.002 | 0.0007 | 0.002 | 0.006 | ||
| MECHVIB | 15.5 | 0.005 | 0.001 | 0.113 | 0.196 | 0.083 | |||
| PEMF | 7.0 | 0.002 | 0.0007 | 0.005 | 0.009 | 0.049 | |||
| VOI-2 | 0.000 | Control | 22.4 | 0.008 | 0.002 | 0.162 | 0.286 | 0.121 | |
| MECHVIB | 61.4 | 0.216 | 0.006 | 0.459 | 0.769 | 0.358 | |||
| PEMF | 34.3 | 0.007 | 0.002 | 0.287 | 0.339 | 0.220 | |||
| VOI-3 | 0.000 | Control | 17.0 | 0.005 | 0.001 | 0.128 | 0.211 | 0.084 | |
| MECHVIB | 47.8 | 0.20 | 0.006 | 0.334 | 0.621 | 0.246 | |||
ANOVA of trabecular-thickness (mm) around implants of test and control groups (n = 15).
| p | Group | Mean | Std. Deviation | Std. Error | 95% Confidence interval for mean | Minimum | |||
| Lower Bound | Upper Bound | ||||||||
| VOI-1 | 0.997 | Control | 0.140 | 0.005 | 0.001 | 0.100 | 0.180 | 0.080 | |
| MECHVIB | 0.141 | 0.002 | 0.008 | 0.121 | 0.161 | 0.105 | |||
| PEMF | 0.142 | 0.005 | 0.001 | 0.104 | 0.179 | 0.090 | |||
| VOI-2 | 0.655 | Control | 0.130 | 0.004 | 0.002 | 0.009 | 0.165 | 0.072 | |
| MECHVIB | 0.147 | 0.002 | 0.009 | 0.125 | 0.168 | 0.105 | |||
| PEMF | 0.133 | 0.004 | 0.001 | 0.100 | 0.166 | 0.082 | |||
| VOI-3 | 0.752 | Control | 0.188 | 0.005 | 0.002 | 0.149 | 0.227 | 0.114 | |
| MECHVIB | 0.198 | 0.005 | 0.002 | 0.162 | 0.234 | 0.133 | |||
Descriptive statistics of trabecular-separation (mm) around implants of test and control groups (n = 15).
| p | Group | Mean | Std. Deviation | Std. Error | 95% Confidence interval for mean | Minimum | |||
| Lower Bound | Upper Bound | ||||||||
| VOI-1 | 0.161 | Control | 0.546 | 0.254 | 0.008 | 0.363 | 0.728 | 0.253 | |
| MECHVIB | 0.530 | 0.221 | 0.007 | 0.372 | 0.688 | 0.106 | |||
| PEMF | 0.718 | 0.229 | 0.007 | 0.554 | 0.882 | 0.402 | |||
| VOI-2 | 0.134 | Control | 0.572 | 0.249 | 0.007 | 0.393 | 0.750 | 0.303 | |
| MECHVIB | 0.521 | 0.204 | 0.006 | 0.375 | 0.668 | 0.122 | |||
| PEMF | 0.725 | 0.225 | 0.007 | 0.563 | 0.886 | 0.412 | |||
| VOI-3 | 0.216 | Control | 0.573 | 0.204 | 0.006 | 0.426 | 0.720 | 0.365 | |
| MECHVIB | 0.474 | 0.168 | 0.005 | 0.354 | 0.595 | 0.190 | |||
ANOVA of trabecular-number (1/mm) around implants of test and control groups (n = 15).
| p | Group | Mean | Std. Deviation | Std. Error | 95% Confidence interval for mean | Minimum | |||
| Lower Bound | Upper Bound | ||||||||
| VOI-1 | 0.003 | Control | 2.027 | 0.830 | 0.262 | 1.432 | 2.621 | 1.305 | |
| MECHVIB | 3.170 | 0.734 | 0.244 | 2.615 | 3.744 | 1.535 | |||
| PEMF | 2.09 | 0.636 | 0.201 | 1.642 | 2.552 | 1.083 | |||
| VOI-2 | 0.025 | Control | 2.214 | 0.786 | 0.248 | 1.651 | 2.777 | 1.413 | |
| MECHVIB | 3.014 | 0.716 | 0.226 | 2.502 | 3.527 | 1.730 | |||
| PEMF | 2.170 | 0.676 | 0.213 | 1.687 | 2.654 | 1.176 | |||
| VOI-3 | 0.006 | Control | 2.051 | 0.576 | 0.182 | 1.638 | 2.463 | 1.479 | |
| MECHVIB | 2.803 | 0.406 | 0.128 | 2.512 | 3.094 | 1.826 | |||
Post Hoc Test (LSD) comparisons between groups.
| BV/TV | Tb.N | |||||
| VOI-1 | VOI-2 | VOI-3 | VOI-1 | VOI-2 | VOI-3 | |
| Control-MECHVIB | 0.00 | 0.00 | 0.00 | 0.002 | 0.021 | 0.003 |
| Control-PEMF | 0.117 | 0.071 | 0.113 | 0.832 | 0.894 | 0.617 |
| MECHVIB-PEMF | 0.00 | 0.00 | 0.001 | 0.004 | 0.015 | 0.009 |